Date published: 2026-5-6

1-800-457-3801

SCBT Portrait Logo
Seach Input

ML-792 (CAS 1644342-14-2)

0.0(0)
Write a reviewAsk a question

Datasheets
CAS Number:
1644342-14-2
Molecular Weight:
551.4
Molecular Formula:
C21H23BrN6O5S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

QUICK LINKS


ML-792 (CAS 1644342-14-2) References

  1. Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor.  |  He, X., et al. 2017. Nat Chem Biol. 13: 1164-1171. PMID: 28892090
  2. Sumoylation as an Emerging Target in Therapeutics against Cancer.  |  Liu, S., et al. 2020. Curr Pharm Des. 26: 4764-4776. PMID: 32568016
  3. SUMOylation stabilizes hSSB1 and enhances the recruitment of NBS1 to DNA damage sites.  |  Zhou, L., et al. 2020. Signal Transduct Target Ther. 5: 80. PMID: 32576812
  4. SUMOylation regulates the protein network and chromatin accessibility at glucocorticoid receptor-binding sites.  |  Paakinaho, V., et al. 2021. Nucleic Acids Res. 49: 1951-1971. PMID: 33524141
  5. Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792.  |  Garcia, P., et al. 2021. Antiviral Res. 188: 105038. PMID: 33577806
  6. Staphylococcus aureus Decreases SUMOylation Host Response to Promote Intramacrophage Survival.  |  Youssouf, N., et al. 2021. Int J Mol Sci. 22: PMID: 34360873
  7. DeSUMOylation of chromatin-bound proteins limits the rapid transcriptional reprogramming induced by daunorubicin in acute myeloid leukemias.  |  Boulanger, M., et al. 2023. Nucleic Acids Res. 51: 8413-8433. PMID: 37462077
  8. SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma.  |  Wang, Z., et al. 2024. Cell Oncol (Dordr). 47: 513-532. PMID: 38055116

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

ML-792, 10 mg

sc-507423
10 mg
$398.00